Hillstar Bio is a biotechnology company specializing in precision immunology therapies aimed at treating autoimmune diseases. The company's innovative approach involves selectively targeting and depleting pathogenic immune cells to potentially reset the immune system, thereby offering more durable therapeutic responses. Hillstar Bio is advancing its lead TRBV9 program through clinical studies for conditions such as axial spondyloarthritis, while also progressing its broader therapeutic pipeline.
Leadership & Board
Current Number of Employees19
Current LinkedIn Followers4,084
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$67M
Total Amount Raised$67M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$67M
Latest Funding Amount$67M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Hillstar Bio had 19 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
19Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Hillstar Bio had 4,084 followers as of October 5, 2026. The number of followers increased by 8 (0.20%) week-over-week.
4,084Latest Followers Count
8(0.20%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.